Correlation Between CureVac NV and Denali Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Denali Therapeutics, you can compare the effects of market volatilities on CureVac NV and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Denali Therapeutics.

Diversification Opportunities for CureVac NV and Denali Therapeutics

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between CureVac and Denali is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of CureVac NV i.e., CureVac NV and Denali Therapeutics go up and down completely randomly.

Pair Corralation between CureVac NV and Denali Therapeutics

Given the investment horizon of 90 days CureVac NV is expected to under-perform the Denali Therapeutics. In addition to that, CureVac NV is 1.09 times more volatile than Denali Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Denali Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest  2,591  in Denali Therapeutics on October 16, 2024 and sell it today you would lose (632.00) from holding Denali Therapeutics or give up 24.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

CureVac NV  vs.  Denali Therapeutics

 Performance 
       Timeline  
CureVac NV 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CureVac NV are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, CureVac NV exhibited solid returns over the last few months and may actually be approaching a breakup point.
Denali Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

CureVac NV and Denali Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CureVac NV and Denali Therapeutics

The main advantage of trading using opposite CureVac NV and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.
The idea behind CureVac NV and Denali Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk